Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Osteosarcoma 5Neuroblastoma 3Breast Neoplasms 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Nerve Sheath Neoplasms 1Neoplasm Metastasis 1Myoepithelioma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Hodgkin Disease 1Giant Cell Tumor of Bone 1Desmoplastic Small Round Cell Tumor 1Clear-cell metastatic renal cell carcinoma 1Chordoma 1Chondrosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Metastatic 1

Interventions

Specimen Handling 9Nivolumab 9Ipilimumab 7cabozantinib 6CTLA-4 Antigen 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Biopsy 4Axitinib 4lenvatinib 2fludarabine 2Blood Specimen Collection 2tivozanib 1sodium-iodide symporter 1sitravatinib 1belzutifan 1aldesleukin 1Zoledronic Acid 1Tissue Banks 1Selenomethionine 1Radiotherapy 1Radiopharmaceuticals 1Pluvicto 1Nephrectomy 1Metastasectomy 1Inulin 1Immunoglobulin G 1Ibandronic Acid 1Hyaluronoglucosaminidase 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Zoledronic Acid × 1 year × Clear all
NCT07043608 2026-05-01

ZAMBONI

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡